Construction of a hTRX-PR39 recombinant adeno-associated virus vector

RUAN Xi-yun,WEI Min,BI Jian-zhong,YANG Guang-xiao,WANG Quan-ying
2011-01-01
Abstract:Objective To construct a vector of recombinant adeno-associated virus(AAV) containing the fusion gene hTRX-PR39,and explore the role of fusion gene hTRX-PR39 as a target gene in the treatment of cerebral ischemic disease.Methods The constructed fusion gene hTRX-PR39 was inserted into the EcoRI-BamHI site of vector plasmid pSSCMV,and the vector of hTRX-PR39 recombinant AAV was constructed.The recombinant AAV stock was packaged.Renal embryo 293 cells were co-transfected with the recombinant AAV vector of plasmid pSSCMV/hTRX-PR39,packaging plasmid pAAV/Ad and helper adenovirus plasmid pFG140.Recombinant AAV was produced by homologous recombination of the 3 plasmids in renal embryo 293 cells and its titer was measured by quantitative dot blot hybridization.Results The vector of hTRX-PR39 recombinant AAV was successfully constructed.High titer of recombinant AAV was obtained by homologous recombination in renal embryo 293 cells(3.46×1012-3.46×1013PFU/mL).Conclusion The recombinant AAV vector encoding the gene hTRX-PR39 was successfully constructed in this study by molecular cloning and in vitro recombination techniques,laying the foundation for further research into genetic therapy of cerebral ischemic disease.
What problem does this paper attempt to address?